Post-approval studies (Phase 4)Study completedNCT01752881
What this trial is testing
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects
Who this might be right for
Influenza
Adimmune Corporation 130